TODD STRATEGY GROUP

Lobbying for AMGEN INC. · Biotechnology company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Oct 11, 2025

Lobbying activity 3

Medicare/Medicaid

Medicare/Medicaid payment reform. Implementation of Inflation Reduction Act of 2022.

Health Issues

Prescription Drug Pricing Policy. Supply Chain Issues.

Taxation/Internal Revenue Code

Prescription drug pricing policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.